TITLE

407 Candesartan is cost-effective in heart failure - an economic analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

PUB. DATE
June 2005
SOURCE
European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Candesartan Is Cost-Effective in Heart Failure--An Economic Analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Programme," by R. Dietz and colleagues is presented.
ACCESSION #
18093833

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics